These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25045326)

  • 21. Metabolic syndrome and the genesis of uric acid stones.
    Maalouf NM
    J Ren Nutr; 2011 Jan; 21(1):128-31. PubMed ID: 21195936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.
    Cameron M; Maalouf NM; Poindexter J; Adams-Huet B; Sakhaee K; Moe OW
    Kidney Int; 2012 Jun; 81(11):1123-30. PubMed ID: 22297671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uric Acid Renal Lithiasis: New Concepts.
    Pazos Pérez F
    Contrib Nephrol; 2018; 192():116-124. PubMed ID: 29393127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who makes uric acid stones and why--observations from a renal stones clinic.
    Stansbridge EM; Griffin DG; Walker V
    J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary alkalization for the treatment of uric acid nephrolithiasis.
    Cicerello E; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2010 Sep; 82(3):145-8. PubMed ID: 21121431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients.
    Li ZX; Jiao GL; Zhou SM; Cheng ZY; Bashir S; Zhou Y
    BMC Nephrol; 2019 Jul; 20(1):273. PubMed ID: 31324154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid nephrolithiasis: An update.
    Cicerello E
    Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
    Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
    J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical treatment of uric acid kidney stones.
    Normand M; Haymann JP; Daudon M
    Can Urol Assoc J; 2024 Nov; 18(11):E339-E345. PubMed ID: 38976892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis.
    Strohmaier WL; Wrobel BM; Schubert G
    Urol Res; 2012 Apr; 40(2):171-5. PubMed ID: 21866382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid stone disease: lessons from recent human physiologic studies.
    Tran TVM; Maalouf NM
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):407-413. PubMed ID: 32398609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with uric acid stones.
    Heilberg IP
    Urolithiasis; 2016 Feb; 44(1):57-63. PubMed ID: 26645868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.
    Capolongo G; Sakhaee K; Pak CY; Maalouf NM
    Urol Res; 2011 Oct; 39(5):367-72. PubMed ID: 21336574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.